# The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-anti-tumor-efficacy-of-cdk4-6-inhibition-is-enhanced-by-the-combination-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniele Cretella,Andrea Ravelli,Claudia Fumarola,Silvia La Monica,Graziana Digiacomo,Andrea Cavazzoni,Roberta Alfieri,Alessandra Biondi,Daniele Generali,Mara Bonelli,Pier Giorgio Petronini |
| Citations | 106 |
| DOI | 10.1186/s13046-018-0741-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jeccr.biomedcentral.com/track/pdf/10.1186/s13046-018-0741-3 |
| OpenAlex ID | https://openalex.org/W2794558033 |
| PMID | 29587820 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Roberta Alfieri](https://scholariq.org/researchers/roberta-alfieri/)
- [Silvia La Monica](https://scholariq.org/researchers/silvia-la-monica/)

## Paper journal

- [Journal of Experimental & Clinical Cancer Research](https://scholariq.org/journals/journal-of-experimental-and-clinical-cancer-research/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.